| Product Code: ETC9516784 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname mycophenolate import market in 2024 continues to be dominated by key exporters such as the Netherlands, India, and Germany, with emerging players like Hong Kong and Guyana also making a significant impact. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market landscape. Despite a moderate Compound Annual Growth Rate (CAGR) of 2.21% from 2020 to 2024, the growth rate has shown a positive trend with a 2.02% increase from 2023 to 2024. This suggests a stable yet slightly accelerating market for mycophenolate import shipments in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Mycophenolate Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Mycophenolate Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Mycophenolate Market - Industry Life Cycle |
3.4 Suriname Mycophenolate Market - Porter's Five Forces |
3.5 Suriname Mycophenolate Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Suriname Mycophenolate Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Suriname Mycophenolate Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 Suriname Mycophenolate Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 Suriname Mycophenolate Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.10 Suriname Mycophenolate Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Mycophenolate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Suriname |
4.2.2 Growing awareness about the benefits of mycophenolate in treating autoimmune disorders |
4.2.3 Favorable government initiatives to improve healthcare infrastructure in Suriname |
4.3 Market Restraints |
4.3.1 High cost associated with mycophenolate treatment |
4.3.2 Limited availability of specialized healthcare professionals for prescribing mycophenolate |
4.3.3 Stringent regulatory requirements for drug approvals in Suriname |
5 Suriname Mycophenolate Market Trends |
6 Suriname Mycophenolate Market, By Types |
6.1 Suriname Mycophenolate Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Suriname Mycophenolate Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Suriname Mycophenolate Market Revenues & Volume, By Selective Immunosuppressants, 2021- 2031F |
6.1.4 Suriname Mycophenolate Market Revenues & Volume, By Antidiarrheals, 2021- 2031F |
6.1.5 Suriname Mycophenolate Market Revenues & Volume, By Somatostatin Analogs, 2021- 2031F |
6.2 Suriname Mycophenolate Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Mycophenolate Market Revenues & Volume, By Immune Thrombocytopenia, 2021- 2031F |
6.2.3 Suriname Mycophenolate Market Revenues & Volume, By Systemic Lupus Erythematosus (SLE), 2021- 2031F |
6.2.4 Suriname Mycophenolate Market Revenues & Volume, By Systemic Sclerosis (SSc), 2021- 2031F |
6.2.5 Suriname Mycophenolate Market Revenues & Volume, By Inflammatory Myopathies, 2021- 2031F |
6.3 Suriname Mycophenolate Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 Suriname Mycophenolate Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 Suriname Mycophenolate Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 Suriname Mycophenolate Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 Suriname Mycophenolate Market Revenues & Volume, By Oral Suspension, 2021- 2031F |
6.4.3 Suriname Mycophenolate Market Revenues & Volume, By Powder for Injection, 2021- 2031F |
6.4.4 Suriname Mycophenolate Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.5 Suriname Mycophenolate Market Revenues & Volume, By Delyed Release Tablet, 2021- 2031F |
6.4.6 Suriname Mycophenolate Market Revenues & Volume, By Capsule, 2021- 2031F |
6.5 Suriname Mycophenolate Market, By End users |
6.5.1 Overview and Analysis |
6.5.2 Suriname Mycophenolate Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Suriname Mycophenolate Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 Suriname Mycophenolate Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Suriname Mycophenolate Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Suriname Mycophenolate Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Suriname Mycophenolate Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Suriname Mycophenolate Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Suriname Mycophenolate Market Import-Export Trade Statistics |
7.1 Suriname Mycophenolate Market Export to Major Countries |
7.2 Suriname Mycophenolate Market Imports from Major Countries |
8 Suriname Mycophenolate Market Key Performance Indicators |
8.1 Patient adherence rate to mycophenolate treatment regimen |
8.2 Number of healthcare facilities offering mycophenolate therapy in Suriname |
8.3 Rate of successful outcomes or remission in patients undergoing mycophenolate treatment |
9 Suriname Mycophenolate Market - Opportunity Assessment |
9.1 Suriname Mycophenolate Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Suriname Mycophenolate Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Suriname Mycophenolate Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 Suriname Mycophenolate Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 Suriname Mycophenolate Market Opportunity Assessment, By End users, 2021 & 2031F |
9.6 Suriname Mycophenolate Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Mycophenolate Market - Competitive Landscape |
10.1 Suriname Mycophenolate Market Revenue Share, By Companies, 2024 |
10.2 Suriname Mycophenolate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here